Related Experiment Video
Updated: Jun 24, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
AmyloidPETNet: Classification of Amyloid Positivity in Brain PET Imaging Using End-to-End Deep Learning.
Shuyang Fan1, Maria Rosana Ponisio1, Pan Xiao1
1From the Department of Bioengineering, Rice University, Houston, Tex (S. Fan); Department of Radiology (S. Fan, M.R.P., P.X., S.M.H., J.J.L., S. Flores, P.L., B.G., C.A.R., D.S.M., A.N., T.L.S.B., A.S.), Charles F. and Joanne Knight Alzheimer Disease Research Center (B.G., B.M.A., R.B., J.C.M., T.L.S.B.), Department of Neurology (C.A.R., B.M.A., R.J.B., J.C.M.), and Institute for Informatics, Data Science and Biostatistics (A.S.), Washington University School of Medicine, 660 S Euclid Ave, Campus Box 8132, St Louis, MO 63110; Duke-NUS Medical School, Singapore (S. Fan); Department of Electrical and Systems Engineering, Washington University in St Louis, St Louis, Mo (S.C., A.S.); Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada (A.N.); and Tracy Family SILQ Center for Neurodegenerative Biology, St Louis, Mo (R.J.B.).
A new deep learning model, AmyloidPETNet, accurately classifies amyloid PET scans as positive or negative. This AI tool reduces reliance on expert radiologists and expensive MRI, improving accessibility for Alzheimer's disease diagnosis.
Area of Science:
- Artificial Intelligence in Medical Imaging
- Neuroimaging Analysis
- Machine Learning for Diagnostics
Background:
- Visual assessment of amyloid PET scans requires radiologist expertise.
- Quantification of amyloid burden often necessitates computationally expensive MRI processing.
- Developing automated methods can enhance accessibility and efficiency in amyloid PET analysis.
Purpose of the Study:
- To develop and evaluate a deep learning model (AmyloidPETNet) for classifying amyloid PET scans.
- To assess the model's performance on independent datasets and various tracers.
- To compare the model's accuracy against human visual reads.
Main Methods:
- Trained AmyloidPETNet on 1538 PET scans (766 patients) and validated on 205 scans (95 patients).
- Tested the model on independent datasets including ADNI, OASIS, and A4 study scans with different tracers.
- Compared model performance using AUC, other metrics, and Cohen κ for physician-model agreement.
Main Results:
- AmyloidPETNet achieved high AUCs (≥0.95) across multiple datasets and tracers, demonstrating strong generalization.
- The model showed excellent performance on ADNI 18F-FBP scans (AUC=0.97) and generalized to other tracers (AUC≥0.97).
- Physician-model agreement varied from fair (Cohen κ=0.39) to almost perfect (Cohen κ=0.93), indicating robust performance.
Conclusions:
- The developed deep learning model accurately classifies amyloid PET scans as positive or negative.
- AmyloidPETNet offers an automated solution, reducing the need for expert readers and structural MRI.
- This AI-driven approach has the potential to improve the efficiency and accessibility of amyloid PET diagnostics.

